Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Pharyngitis01:30

Acute Pharyngitis

5.2K
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
5.2K
Stages of Infection01:26

Stages of Infection

66.5K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
66.5K
Vaccinations01:51

Vaccinations

53.2K
Overview
53.2K
Leaky Scanning02:28

Leaky Scanning

5.8K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beta Blockers to Improve Post-MI Outcomes in Patients Without HF.

American family physician·2026
Same author

Latent tuberculosis infection care cascade outcomes in primary care clinics in the tuberculosis epidemiologic studies consortium-III.

Annals of epidemiology·2026
Same author

Hyperthyroidism: Diagnosis and Treatment.

American family physician·2025
Same author

High-Flow Nasal Cannula Therapy for Infants With Bronchiolitis.

American family physician·2025
Same author

Bempedoic Acid for the Prevention of Cardiovascular Disease.

American family physician·2024
Same author

Antibiotics for Acute Uncomplicated Diverticulitis.

American family physician·2023

Related Experiment Video

Updated: Mar 14, 2026

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

19.2K

Does oseltamivir shorten flu symptom duration?

Richard Broadhurst1, Anne Mounsey1

  • 1University of North Carolina Family Practice Residency Program, Chapel Hill, USA.

The Journal of Family Practice
|September 24, 2016
PubMed
Summary
This summary is machine-generated.

Oral oseltamivir effectively treats influenza virus infection in adults and children. This antiviral medication significantly reduces symptom duration, even when treatment begins after two days of symptom onset.

More Related Videos

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation
09:04

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation

Published on: September 7, 2010

12.0K
Optimization of a Quantitative Micro-neutralization Assay
10:09

Optimization of a Quantitative Micro-neutralization Assay

Published on: December 14, 2016

22.0K

Related Experiment Videos

Last Updated: Mar 14, 2026

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

19.2K
Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation
09:04

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation

Published on: September 7, 2010

12.0K
Optimization of a Quantitative Micro-neutralization Assay
10:09

Optimization of a Quantitative Micro-neutralization Assay

Published on: December 14, 2016

22.0K

Area of Science:

  • Virology
  • Infectious Diseases
  • Pharmacology

Background:

  • Influenza virus infections pose a significant global health burden.
  • Antiviral medications are crucial for managing influenza symptoms and reducing transmission.
  • Oseltamivir is a widely used neuraminidase inhibitor for influenza treatment.

Purpose of the Study:

  • To evaluate the efficacy of oral oseltamivir in reducing symptom duration for influenza virus infections.
  • To assess the impact of oseltamivir initiation timing on symptom alleviation.

Main Methods:

  • The study involved treatment of influenza virus infection with oral oseltamivir.
  • A placebo group was used for comparison.
  • Symptom duration was the primary outcome measure.

Main Results:

  • Oral oseltamivir treatment reduced the time to symptom alleviation by approximately one day compared to placebo.
  • The benefits of oseltamivir were observed even when treatment was initiated more than 2 days after symptom onset.

Conclusions:

  • Oral oseltamivir is an effective treatment for influenza virus infection in both adults and children.
  • Early or delayed initiation of oseltamivir can lead to a reduction in symptom duration.